Back to results
US 2024/0245783 A1Published application
Metallo-beta-lactamase inhibitor
AssigneeNational University Corporation Kumamoto University
InventorsTomohiro SAWA, Yoshihiro YAMAGUTI, Yoshichika ARAKAWA
Life of this patent
Estimating the term…
Abstract
A compound represented by formula (I), formula (II), or formula (IV), or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition containing the compound or a pharmaceutically acceptable salt thereof, for use in inhibiting metallo-β-lactamases.
Claims14
A compound represented by formula (I), formula (II), or formula (IV):
- or a pharmaceutically acceptable salt thereof, wherein
- Q is a direct bond or a group:
- —N(—R2)—CH(—R1)—C(═O)—, wherein a nitrogen atom of the group is linked to a carbonyl group described in formula (I) or formula (II);
- R1 is phenyl optionally substituted with one or more substituents selected from X1, 5- or 6-membered heteroaryl optionally substituted with one or more substituents selected from X1, C1-10 alkyl optionally substituted with one or more substituents selected from X2, C2-10 alkenyl optionally substituted with one or more substituents selected from X2, C2-10 alkynyl optionally substituted with one or more substituents selected from X2, C3-10 cycloalkyl optionally substituted with one or more substituents selected from X2, or C6-10 cycloalkanedienyl optionally substituted with one or more substituents selected from X3;
- R2 is a hydrogen atom or C1-6 alkyl;
- R3 is a hydrogen atom or C1-6 alkyl;
- R4 is a hydrogen atom, C1-6 alkyl optionally substituted with one or more substituents selected from X4, or 5- or 6-membered non-aromatic heterocyclyloxy optionally substituted with one or more substituents selected from X5, wherein the heterocyclyl of the non-aromatic heterocyclyloxy is optionally fused with a benzene ring;
- R5 is a hydrogen atom, a halogen atom, C1-6 alkyl, C1-6 alkoxy, C2-6 alkenyl optionally substituted with R6, or methyl substituted with R7;
- R6 is phenyl optionally substituted with one or more substituents selected from X1, or 5- or 6-membered heteroaryl optionally substituted with one or more substituents selected from X1;
- R7 is 5- or 6-membered heteroarylsulfanyl optionally substituted with one or more substituents selected from X5, 5 or 6-membered heteroaryloxy optionally substituted with one or more substituents selected from X5, phenylsulfanyl optionally substituted with one or more substituents selected from X5, phenyloxy optionally substituted with one or more substituents selected from X5, (C1-6 alkyl)carbonyloxy, carbamoyloxy, pyridinium-1-yl optionally fused with C5-7 cycloalkyl and optionally substituted with X5, or 1-methylpyrrolidinium-1-yl optionally substituted with X5;
- X1 is amino, hydroxy, C1-6 alkyl, C1-6 alkoxy, a halogen atom, or phenyl optionally substituted with one or more halogen atoms or hydroxy;
- X2 is amino, hydroxy, C1-6 alkoxy, a halogen atom, carboxy, or (C1-6 alkoxy)carbonyl;
- X3 is C1-6 alkyl or a halogen atom;
- X4 is (C1-6 alkyl)carbonyloxy or (C1-6 alkoxy)carbonyloxy;
- X5 is C1-6 alkyl optionally substituted with R8, or carbamoyl;
- X6 is C1-6 alkyl, a halogen atom, (C1-6 alkoxy)carbonyl, or carboxy;
- R8 is hydroxy, sulfo, or carboxy;
- R9 is a hydrogen atom or methyl;
- Ra is a polyamine group represented by any of the following formulae:
- and ● indicates the bonding position;
- and
- Rb is selected from a group represented by the following formula:
- Q1 is C2-6 alkylene;
- R10 is a hydrogen atom, C1-6 alkyl, or —CH═NH;
- R11 and R12 are each independently a hydrogen atom or C1-6 alkyl;
- R13 is a hydrogen atom, C1-6 alkyl, —CH2NHSO2NH2, or —CONR14R15, wherein the alkyl is optionally substituted with one or more substituents selected from —NR14R15 and hydroxy;
- R14 is a hydrogen atom, C1-6 alkyl, or phenyl optionally substituted with one or more substituents selected from X6;
- and
- R15 is a hydrogen atom or C1-6 alkyl.
26 more elements
Dependencies are inferred from the claim text.